Education
About Us
Working with TipRanks
Follow Us
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Ap1189, 100 Mg, Ap1189, 40 Mg, Ap1189, 70 Mg
Rheumatoid Arthritis (Ra)
Phase II
Recruiting
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Oct 31, 2024
―
Ap1189, 60 Mg, Ap1189, 80 Mg, Ap1189, 100 Mg
Rheumatoid Arthritis
Phase II
Completed
A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Oct 31, 2022
―
100 Mg Ap1189
Nephrotic Syndrome Due To Idiopathic Membranous Nephropathy, Severe Proteinuria Due To Idiopathic Membranous Nephropathy
Phase II
Recruiting
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria
Jun 24, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does SynAct Pharma AB (SYNACT) have in its pipeline
SYNACT is currently developing the following drugs: Ap1189, 100 Mg, Ap1189, 40 Mg, Ap1189, 70 Mg, Ap1189, 60 Mg, Ap1189, 80 Mg, Ap1189, 100 Mg, 100 Mg Ap1189. These drug candidates are in various stages of clinical development as the company works toward FDA approval.